Tata Capital Reports 98% Utilization of IPO Proceeds in Q3 FY26 Monitoring Report
Tata Capital Limited's Q3 FY26 monitoring report shows 98% utilization of ₹6,846 crore fresh issue proceeds from its October 2025 IPO. CARE Ratings confirmed no deviations from stated objectives, with ₹6,697 crores deployed for Tier-1 capital augmentation and ₹21 crores for issue expenses, leaving ₹128 crores unutilized.

*this image is generated using AI for illustrative purposes only.
Tata Capital Limited has filed its quarterly monitoring agency report with stock exchanges, showcasing efficient utilization of proceeds from its Initial Public Offering (IPO). The report, prepared by CARE Ratings Limited for the quarter ended December 31, 2025, indicates that the company has deployed 98% of its fresh issue proceeds in accordance with the stated objectives.
IPO Details and Fund Deployment
The company's IPO, conducted from October 6-8, 2025, raised a total of ₹15,512 crores, making it one of the significant public offerings in the non-banking financial services sector. The issue structure comprised two components: a fresh issue worth ₹6,846 crores and an offer for sale amounting to ₹8,666 crores.
| Parameter | Details |
|---|---|
| Issue Period | October 6-8, 2025 |
| Total Issue Size | ₹15,512 crores |
| Fresh Issue | ₹6,846 crores |
| Offer for Sale | ₹8,666 crores |
| Promoter | Tata Sons Private Limited |
| Monitoring Agency | CARE Ratings Limited |
Fund Utilization Progress
According to the monitoring agency report, the fresh issue proceeds have been systematically deployed across the planned objectives. The primary allocation was directed toward augmenting the company's Tier-1 capital to meet future capital requirements, including onward lending activities arising from business growth.
| Objective | Allocated Amount | Utilized Amount | Utilization Status |
|---|---|---|---|
| Tier-1 Capital Augmentation | ₹6,697 crores | ₹6,697 crores | 100% |
| Issue Expenses | ₹149 crores | ₹21 crores | 14% |
| Total | ₹6,846 crores | ₹6,718 crores | 98% |
Specific Fund Deployment
The monitoring report provides detailed insights into how the Tier-1 capital augmentation funds were utilized. Out of the ₹6,697 crores allocated for this purpose, ₹5,200 crores was specifically used for repayment of borrowings, while ₹1,497 crores was deployed toward onward lending activities. This strategic allocation aligns with the company's growth objectives in the non-banking financial services sector.
Unutilized Proceeds Management
As of December 31, 2025, ₹128 crores remains unutilized, primarily consisting of pending issue expenses. The monitoring agency noted that the total estimated issue-related expenses amount to ₹326 crores, shared among Tata Sons Limited, International Finance Corporation, and Tata Capital Limited. The company's share of the closing balance stands at ₹128 crores, while ₹145 crores is attributable to the other two parties involved in the offer for sale.
Compliance and Monitoring
CARE Ratings Limited, in its capacity as the monitoring agency, confirmed that all utilization aligns with disclosures made in the offer document. The report indicates no deviations from the stated objectives, no changes in the means of finance for disclosed objects, and no major deviations from earlier monitoring reports. All necessary government and statutory approvals related to the objectives have been obtained.
Timeline Performance
The company demonstrated efficient execution by completing the Tier-1 capital augmentation objective ahead of schedule. While the offer document specified a completion date of March 31, 2026, the company achieved this milestone by October 14, 2025, indicating strong project management and execution capabilities.
The Board of Directors and Audit Committee reviewed and approved the monitoring agency report during their meetings held on January 17, 2026, and January 19, 2026, respectively, confirming that the net proceeds were utilized for purposes stated in the prospectus without any material deviations.
Historical Stock Returns for Tata Capital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.25% | +0.07% | +10.44% | +9.00% | +9.00% | -64.99% |















































